TradingView
warrenhochfeld
1 de Nov de 2017 19:02

Dynavax final breakout ahead of PDUFA Heplisav announcement  Viés de alta

Dynavax Technologies CorporationNASDAQ

Descrição

Start of final bull run ahead of 9th November FDA announcement of Heplisav . $28 price projection. Final buy opportunity at $20
Mais